These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36644198)

  • 1. COVID-19 Vaccines: Computational tools and Development.
    Osamor VC; Ikeakanam E; Bishung JU; Abiodun TN; Ekpo RH
    Inform Med Unlocked; 2023; 37():101164. PubMed ID: 36644198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Vaccines: Where Are We Now?
    Flanagan KL; MacIntyre CR; McIntyre PB; Nelson MR
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3535-3543. PubMed ID: 34400116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease.
    Belete TM
    Infect Drug Resist; 2021; 14():151-161. PubMed ID: 33500636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccines and nanomedicine.
    Shapiro RS
    Int J Dermatol; 2021 Sep; 60(9):1047-1052. PubMed ID: 34089534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress and challenge of vaccine development against 2019-novel coronavirus (2019-nCoV)].
    Shi Y; Wang N; Zou QM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jun; 54(6):614-619. PubMed ID: 32234130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction.
    Akhtar N; Joshi A; Singh B; Kaushik V
    Infect Disord Drug Targets; 2021; 21(4):541-552. PubMed ID: 32957905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous adverse effects of the available COVID-19 vaccines.
    Bogdanov G; Bogdanov I; Kazandjieva J; Tsankov N
    Clin Dermatol; 2021; 39(3):523-531. PubMed ID: 34518015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool.
    Todorov G; Uversky VN
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33066343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Next-Generation Coronavirus Vaccines in Response to Future Virus Evolution.
    Li L; Wei Y; Yang H; Yan J; Li X; Li Z; Zhao Y; Liang H; Wang H
    Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world.
    Chavda VP; Yao Q; Vora LK; Apostolopoulos V; Patel CA; Bezbaruah R; Patel AB; Chen ZS
    Front Immunol; 2022; 13():961198. PubMed ID: 36263030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.
    Shih HI; Wu CJ; Tu YF; Chi CY
    Biomed J; 2020 Aug; 43(4):341-354. PubMed ID: 32532623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of COVID-19 vaccines.
    Graña C; Ghosn L; Evrenoglou T; Jarde A; Minozzi S; Bergman H; Buckley BS; Probyn K; Villanueva G; Henschke N; Bonnet H; Assi R; Menon S; Marti M; Devane D; Mallon P; Lelievre JD; Askie LM; Kredo T; Ferrand G; Davidson M; Riveros C; Tovey D; Meerpohl JJ; Grasselli G; Rada G; Hróbjartsson A; Ravaud P; Chaimani A; Boutron I
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD015477. PubMed ID: 36473651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders.
    Khare S; Niharika ; Singh A; Hussain I; Singh NB; Singh S
    Appl Biochem Biotechnol; 2023 Feb; 195(2):1541-1573. PubMed ID: 36222988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling and tracking Covid-19 cases using Big Data analytics on HPCC system platformm.
    Villanustre F; Chala A; Dev R; Xu L; LexisNexis JS; Furht B; Khoshgoftaar T
    J Big Data; 2021; 8(1):33. PubMed ID: 33614394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.